Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 4,284 | 3,752 | 3,080 | 3,308 | 2,654 |
| Cost of Goods | 102 | 168 | 42 | 119 | 104 |
| Gross Profit | 4,182 | 3,585 | 3,039 | 3,190 | 2,550 |
| Operating Expenses | 5,422 | 5,311 | 4,382 | 4,502 | 3,940 |
| Operating Income | -1,138 | -1,559 | -1,302 | -1,194 | -1,286 |
| Interest Expense | 126 | 125 | 123 | 126 | 126 |
| Other Income | 108 | 113 | 119 | 127 | 99 |
| Pre-tax Income | -1,156 | -1,571 | -1,306 | -1,193 | -1,312 |
| Net Income Continuous | -1,156 | -1,571 | -1,306 | -1,193 | -1,312 |
| Net Income | $-1,156 | $-1,571 | $-1,306 | $-1,193 | $-1,312 |
| EPS Basic Total Ops | -0.45 | -0.62 | -0.51 | 1.15 | -0.94 |
| EPS Basic Continuous Ops | -0.45 | -0.62 | -0.51 | 1.14 | -0.94 |
| EPS Diluted Total Ops | -0.45 | -0.62 | -0.51 | 1.15 | -0.94 |
| EPS Diluted Continuous Ops | -0.45 | -0.62 | -0.51 | 1.14 | -0.94 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.62 | -0.51 | -0.49 | -0.94 |
| EBITDA(a) | $-1,138 | $-1,559 | $-1,302 | $-1,194 | $-1,286 |